So for insulin, the volume measurement and the dose measurement align perfectly
Compounded 2.5mg/ml Injectable Semaglutide Suggested Dose: Inject 0.1ml once weekly subcutaneously weeks 1-4, Increase dose to 0.2ml once weekly on weeks 5-8, increase dose to 0.4ml once weekly on weeks 9-12, increase dose to 0.68ml once weekly on weeks 13-16, if a dosage increase is still needed, increase to 0.96ml once weekly for maintenance
The 5mg vial is appropriate for short-term pilot studies or researchers establishing initial dose-response relationships
However, they promote weight loss through mechanisms that function independently of leptin signalling, potentially offering benefits even when leptin pathways are impaired
No major guideline recommends measuring endogenous GLP-1 levels before initiating treatment
Pharmaceutical economics suggest Retatrutide will command premium pricing initially, potentially higher than Tirzepatide